Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Benefits Magazine: 7 Questions Toward More Effective Workers' Comp Programs
In trying to ensure workers' compensation programs work for both employees and their organization, employers need to consider at least seven key areas.
3 For NWCDC: Ron Skrocki of GENEX Services
During our time at NWCDC 2014, we had Workers’ Comp industry stakeholders participate in WorkCompWire’s “3 For NWCDC” series, focused on this year’s developments and on improving the system! Here’s what Ron Skrocki, VP Product Management and Development at GENEX Services had to say:
WorkCompWire: Archie Anderson: Time for a Fresh Look at the Independent Medical Exam
For years the Independent Medical Exam (IME) has been a staple in the workers’ compensation claims resolution arsenal.
Genex Services Acquires Leading Case Management Firm M Hayes
Genex Services Acquires Leading Case Management Firm M Hayes Acquisition extends Genex's position as largest case management provider in nation
Genex Social Security Division Receives Supplier of the Year Award from Unum
WAYNE, Pa.
Transforming Big Data into Applied Analytics
What are the best practices for turning Big Data into actional decisions?